INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Novo Nordisk To Contact Him Directly To Discuss Their ...
Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...
Notable Healthcare headlines for the week: Moderna, AbbVie, Thermo Fisher, J&J in focus
Major stock indexes closed lower on Friday, after the week saw a flurry of events, including DeepSeek scare and earnings ...
Axios Charlotte on MSN9h
Weight-loss drug demand surges across North Carolina
From Aug. 1 to the end of the year, Medicaid beneficiaries received 33,035 claims for GLP-1 drugs for weight loss, a number ...
Here's why researchers think most people stop taking weight loss drugs within a year
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
Euro Weekly News2h
Denmark to pull the plug on Ozempic for Americans amid Trump’s Greenland threats?
Denmark may curb exports of weight loss drugs Ozempic and Wegovy, as well as Lego, if Trump plans to buy Greenland. Tariffs ...
wusf6h
About half of Americans approve of using weight-loss drugs to treat obesity, a poll finds
The AP-NORC survey shows about half of U.S. adults believe it is a good thing for adults to use Ozempic, Wegovy and similar ...